First Pacific Advisors LLC increased its position in CVS Health Corporation (NYSE:CVS) by 7.6% during the second quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 114,190 shares of the pharmacy operator’s stock after buying an additional 8,050 shares during the period. First Pacific Advisors LLC’s holdings in CVS Health Corporation were worth $10,933,000 at the end of the most recent reporting period.

Other hedge funds also recently added to or reduced their stakes in the company. MU Investments Co. Ltd. increased its stake in CVS Health Corporation by 62.0% in the second quarter. MU Investments Co. Ltd. now owns 1,150 shares of the pharmacy operator’s stock worth $109,000 after buying an additional 440 shares during the last quarter. Springbok Capital Management LLC increased its stake in CVS Health Corporation by 190.5% in the first quarter. Springbok Capital Management LLC now owns 1,130 shares of the pharmacy operator’s stock worth $117,000 after buying an additional 741 shares during the last quarter. Global X Management Co. LLC increased its stake in CVS Health Corporation by 93.5% in the second quarter. Global X Management Co. LLC now owns 1,362 shares of the pharmacy operator’s stock worth $130,000 after buying an additional 658 shares during the last quarter. Alexandria Capital LLC increased its stake in CVS Health Corporation by 3.4% in the second quarter. Alexandria Capital LLC now owns 1,405 shares of the pharmacy operator’s stock worth $135,000 after buying an additional 46 shares during the last quarter. Finally, Arcadia Investment Management Corp MI increased its stake in CVS Health Corporation by 87.7% in the second quarter. Arcadia Investment Management Corp MI now owns 1,605 shares of the pharmacy operator’s stock worth $154,000 after buying an additional 750 shares during the last quarter. 80.96% of the stock is owned by institutional investors and hedge funds.

CVS Health Corporation (NYSE:CVS) traded down 0.26% during trading on Wednesday, reaching $89.76. The company’s stock had a trading volume of 4,147,835 shares. The firm has a market cap of $95.70 billion, a P/E ratio of 20.65 and a beta of 0.84. CVS Health Corporation has a 52 week low of $86.50 and a 52 week high of $106.67. The stock’s 50 day moving average is $94.64 and its 200-day moving average is $97.97.

CVS Health Corporation (NYSE:CVS) last announced its earnings results on Tuesday, August 2nd. The pharmacy operator reported $1.32 EPS for the quarter, topping the consensus estimate of $1.30 by $0.02. The company had revenue of $43.70 billion for the quarter, compared to analysts’ expectations of $44.28 billion. CVS Health Corporation had a return on equity of 15.86% and a net margin of 2.88%. The business’s revenue for the quarter was up 17.6% on a year-over-year basis. During the same quarter in the prior year, the business earned $1.19 earnings per share. On average, equities research analysts forecast that CVS Health Corporation will post $5.86 earnings per share for the current fiscal year.

A number of research firms have recently weighed in on CVS. Leerink Swann reaffirmed a “buy” rating on shares of CVS Health Corporation in a report on Friday, June 10th. Credit Suisse Group AG reaffirmed a “buy” rating and issued a $115.00 price objective on shares of CVS Health Corporation in a report on Sunday, June 5th. Jefferies Group reaffirmed a “buy” rating on shares of CVS Health Corporation in a report on Monday, July 4th. Mizuho reaffirmed a “buy” rating and issued a $108.00 price objective (down previously from $117.00) on shares of CVS Health Corporation in a report on Thursday, June 23rd. Finally, Argus reaffirmed a “buy” rating and issued a $120.00 price objective on shares of CVS Health Corporation in a report on Thursday, August 4th. Six research analysts have rated the stock with a hold rating, seventeen have assigned a buy rating and one has assigned a strong buy rating to the stock. CVS Health Corporation presently has an average rating of “Buy” and a consensus target price of $113.02.

CVS Health Corporation Company Profile

CVS Health Corporation, together with its subsidiaries, is a pharmacy company. The Company operates through three business segments: Pharmacy Services, Retail Pharmacy and Corporate. The Pharmacy Services segment provides a range of pharmacy benefit management (PBM) services and operates under the CVS/caremark Pharmacy Services, Novologix and Navarro Health Services names.

5 Day Chart for NYSE:CVS

Receive News & Ratings for CVS Health Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CVS Health Corporation and related companies with MarketBeat.com's FREE daily email newsletter.